Pharmacy news

• Why Mild Tardive Dyskinesia Is Often the Hardest To Manage

  03-02-2026 17:27 via pharmacypracticenews.com
  figure img { width:100% !important; } figcaption { padding: 5px; background: transparent; word-wrap: normal; text-align: center; font-size:10px; line-height: 12px; }Credit: Doucefleur-stock.adobe.com.By Gina ShawSevere tardive dyskinesia (TD) is rarely subtle. When abnormal movements are pronounced, disruptive, or socially disabling, the need for intervention is usually clear. By contrast, mild TD—often intermittent, easily masked, and variably bothersome—can create some of the most
  
  Read more

• Why Long-Term TD Management Still Falls Through the Cracks

  03-02-2026 17:27 via pharmacypracticenews.com
  By Gina ShawThe growing recognition of tardive dyskinesia (TD) as a treatable condition has shifted attention away from whether therapy exists to a more complicated question: Once TD has been identified, who is responsible for managing it over time?“Tardive dyskinesia has historically been thought of as a medication-induced adverse event, but it’s a diagnosable condition,” said Stephen Saklad, PharmD, BCCP, a clinical professor emeritus at The University of Texas at Austin Coll
  
  Read more

• New York Cannabis Program Leading to Opioid Reduction

  03-02-2026 13:26 via pharmacypracticenews.com
  Originally published by our sister publication Pain Medicine NewsBy Kenny WalterNew research shows adults with chronic pain are less likely to require prescription opioids if they participate in the New York State (NYS) Medical Cannabis Program, a government initiative aimed at implementing a regulatory framework for medical and adult-use cannabis and hemp in New York.figure img { width:100% !important; } figcaption { padding: 5px; background: transparent; word-wrap: normal; text-align: center;
  
  Read more

• Diversion Software Success Hinges on Trust, Workflow, and Follow-Through

  03-02-2026 13:23 via pharmacypracticenews.com
  By Gina ShawDrug diversion software implementations often stall not because of technical shortcomings, but because of predictable human and workflow challenges that go unaddressed, said Thomas Latuga, PharmD, MHA, BCPS, the director of pharmacy at Niagara Falls Memorial Medical Center, in New York, during a session at ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas.figure img { width:100% !important; } figcaption { padding: 5px; background: transparent; word-wrap: normal; text-
  
  Read more

• Advertisement

Follow @newsl_pharmacy on Twitter!